CLINIMADE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CLINIMADE
Largest movements
- Tangible fixed assets -€19,517
down €19,517 (-5.1%), from €385,302 to €365,785
- Debts after one year -€30,331
down €30,331 (-11.0%), from €275,525 to €245,194
of which Financial debts: -€25,135
- Profit (loss) carried forward +€9,867
up €9,867 (+37.1%), from €26,564 to €36,432
- Gross operating margin +€2,186
up €2,186 (+6.0%), from €36,580 to €38,767
- Taxes +€586
up €586 (+21.7%), from €2,703 to €3,289
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €389,230 | €369,588 | -€19,642 | -5.0% |
| Fixed assets | 21/28 | €385,302 | €365,785 | -€19,517 | -5.1% |
| Tangible fixed assets | 22/27 | €385,302 | €365,785 | -€19,517 | -5.1% |
| Land and buildings | 22 | €385,302 | €365,785 | -€19,517 | -5.1% |
| Current assets | 29/58 | €3,928 | €3,803 | -€125 | -3.2% |
| Amounts receivable within one year | 40/41 | €0 | - | = | |
| Other amounts receivable | 41 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €3,928 | €3,803 | -€125 | -3.2% |
| Deferred charges and accrued income | 490/1 | €0 | - | = | |
| Total equity and liabilities | 10/49 | €389,230 | €369,588 | -€19,642 | -5.0% |
| Equity | 10/15 | €88,264 | €98,132 | +€9,867 | +11.2% |
| Contributions | 10/11 | €60,000 | €60,000 | = | 0.0% |
| Reserves | 13 | €1,700 | €1,700 | = | 0.0% |
| Distributable reserves | 133 | €1,700 | €1,700 | = | 0.0% |
| Profit (loss) carried forward | 14 | €26,564 | €36,432 | +€9,867 | +37.1% |
| Amounts payable | 17/49 | €300,966 | €271,456 | -€29,509 | -9.8% |
| Amounts payable after more than one year | 17 | €275,525 | €245,194 | -€30,331 | -11.0% |
| Financial debts | 170/4 | €193,505 | €168,370 | -€25,135 | -13.0% |
| Other amounts payable | 178/9 | €82,020 | €76,824 | -€5,197 | -6.3% |
| Amounts payable within one year | 42/48 | €25,441 | €26,263 | +€822 | +3.2% |
| Current portion of amounts payable after more than one year | 42 | €24,729 | €25,135 | +€406 | +1.6% |
| Trade debts | 44 | €508 | €339 | -€170 | -33.4% |
| Suppliers | 440/4 | €508 | €339 | -€170 | -33.4% |
| Taxes, remuneration and social security | 45 | €203 | €789 | +€586 | +288.0% |
| Taxes | 450/3 | €203 | €789 | +€586 | +288.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €19,517 | €19,517 | = | 0.0% |
| Other operating charges | 640/8 | €2,235 | €2,305 | +€70 | +3.1% |
| Gross operating margin | 9900 | €36,580 | €38,767 | +€2,186 | +6.0% |
| Operating profit (loss) | 9901 | €14,829 | €16,945 | +€2,116 | +14.3% |
| Financial charges | 65/66B | €4,015 | €3,789 | -€227 | -5.6% |
| Recurring financial charges | 65 | €4,015 | €3,789 | -€227 | -5.6% |
| Profit (loss) for the period before taxes | 9903 | €10,814 | €13,156 | +€2,343 | +21.7% |
| Income taxes | 67/77 | €2,703 | €3,289 | +€586 | +21.7% |
| Profit (loss) for the period | 9904 | €8,110 | €9,867 | +€1,757 | +21.7% |
| Profit (loss) for the period to be appropriated | 9905 | €8,110 | €9,867 | +€1,757 | +21.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.